Combining microbial and chemical syntheses for the production of complex natural products.
10.1016/S1875-5364(22)60191-2
- Author:
Haili ZHANG
1
;
Xiaoyu TANG
2
Author Information
1. Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen 518132, China.
2. Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen 518132, China. Electronic address: xtang@szbl.ac.cn.
- Publication Type:Review
- Keywords:
Biosynthesis;
Brasilicardins;
Chemical syntheses;
Microbial
- MeSH:
Biological Products/chemistry*;
Aminoglycosides
- From:
Chinese Journal of Natural Medicines (English Ed.)
2022;20(10):729-736
- CountryChina
- Language:English
-
Abstract:
Nature, a rich source of bioactive natural products, serves as a massive pool of drug candidates for the pharmaceutical industry. However, the supply of these structurally complex chemicals is costly as most of the natural products are scarce in nature, thus requiring de novo synthesis. The supply chain issue hinders the development of novel therapeutic agents from natural products. Microbial synthesis, based on the expression of biosynthetic genes in a suitable microbial host to produce certain chemicals, is a sustainable strategy to produce complex natural products. However, this strategy requires gaining insights into the biosynthesis of target molecules. Most natural products are biosynthetically unknown or not fully elucidated; thus, the sole application of microbial synthesis strategy to produce a given molecule is challenging. In this review, we highlight a strategy that combines microbial and chemical syntheses to tackle the supply chain issue in developing drugs from natural products. We believe this strategy can revive the drug development pipeline for natural products.
